<DOC>
	<DOCNO>NCT00404196</DOCNO>
	<brief_summary>To compare efficacy safety two different dose combination LEO19123 cream ( calcipotriol LEO80122 ) LEO19123 cream vehicle 3 week treatment patient hand eczema .</brief_summary>
	<brief_title>LEO19123 Cream Treatment Hand Eczema</brief_title>
	<detailed_description />
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<criteria>Clinical diagnosis hand eczema without atopic etiology/background Investigator.s Global Assessment disease severity grade least mild Visit 1 Patients Caucasian male age 18 year Attending hospital outpatient clinic private practise dermatologist . Following verbal write information trial , patient must provide sign date informed consent trial related activity carry , include activity relate washout period . Systemic treatment immunosuppressive drug ( e.g . methotrexate , cyclosporine , azathioprine ) corticosteroid within 4 week prior randomisation . ( Inhaled intranasal steroid asthma rhinitis may use ) . PUVA UVB therapy hand within 4 week prior randomisation . Topical treatment immunomodulators ( pimecrolimus , tacrolimus ) corticosteroid WHO group III IV hand within 2 week prior randomisation . Other topical therapy hand ( except use emollient ) within 1 week prior randomisation . Use treatment ( drug , nondrug ) hand trial except use investigational product emollient . Concurrent skin disease hand . Current diagnosis exfoliative dermatitis . Significant clinical infection ( impetiginised hand eczema ) hand , require antibiotic treatment . Known suspected hypersensitivity component ( ) investigational product . Positive patch test define protocol Known suspect severe renal insufficiency severe hepatic disorder . Patients history/signs/symptoms suggestive abnormality calcium homeostasis associate clinically significant hypercalcaemia . Patients history cancer except basal cell carcinoma . Current participation interventional clinical trial . Patients receive treatment nonmarketed drug substance ( i.e . agent yet make available clinical use follow registration ) within 4 week prior randomisation . Previously randomise study . Patients know , opinion investigator , unlikely comply Clinical Study Protocol ( e.g . alcoholism , drug dependency , psychotic state ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>